Active Surveillance for Low-Risk Differentiated Thyroid Cancer

Area of Science:

• Endocrinology
• Oncology

Background:

• Less aggressive treatment options like hemithyroidectomy and active surveillance are now accepted for low-risk differentiated thyroid carcinoma (DTC).
• Studies indicate a low incidence of cancer progression and metastasis in DTC patients managed with active surveillance.

Purpose of the Study:

• To outline criteria for identifying appropriate candidates for active surveillance in low-risk DTC.
• To highlight factors beyond clinical presentation that influence the suitability of active surveillance for DTC patients.

Main Methods:

• Review of existing literature on active surveillance for differentiated thyroid carcinoma.
• Analysis of clinical guidelines and expert consensus regarding patient selection for DTC management.

Main Results:

• Active surveillance is suitable for low-risk DTC without tracheal or recurrent laryngeal nerve involvement, extrathyroidal extension, high-risk molecular markers, or nodal/distant metastases.
• Factors such as patient finances, insurance, availability of expert medical resources, and patient preferences are critical considerations.

Conclusions:

• While active surveillance offers a less aggressive approach for select low-risk DTC patients, careful assessment of both tumor characteristics and patient-specific factors is essential.
• Personalized treatment strategies, incorporating patient-physician shared decision-making, are key for optimizing outcomes in differentiated thyroid carcinoma.